
SCPH
Healthcare · Biotechnology · $304.4M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2025
EPS trend, 90 days to now · +0.4% over 90 days · 30-day revisions 0 up, 2 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Mar 25, 2026 | Time not confirmed | -0.17 | 0.00 | +100.0% |
| Nov 5, 2025 | Time not confirmed | -0.23 | 0.00 | +100.0% |
| Aug 7, 2025 | Time not confirmed | -0.29 | -0.34 | -17.2% |
| May 12, 2025 | Before the open | -0.28 | -0.37 | -29.8% |
| Mar 11, 2025 | Before the open | -0.39 | -0.31 | +19.5% |
| Nov 6, 2024 | After the close | -0.30 | -0.28 | +6.7% |
| Aug 8, 2024 | Before the open | -0.40 | -0.44 | -10.0% |
| May 14, 2024 | After the close | -0.44 | -0.36 | +18.2% |
| Mar 13, 2024 | After the close | -0.42 | -0.35 | +16.7% |
| Nov 8, 2023 | After the close | -0.36 | -0.41 | -13.9% |
| Aug 10, 2023 | After the close | -0.37 | -0.36 | +2.7% |
| May 10, 2023 | After the close | -0.36 | -0.30 | +16.7% |
| Mar 22, 2023 | After the close | -0.39 |
scPharmaceuticals Inc., a pharmaceutical company, focuses on developing and commercializing products to optimize the delivery of infused therapies and patient care. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for the treatment of congestion due to fluid overload in adults with chronic heart failure and kidney disease, as…
| -0.30 |
| +23.1% |
| Nov 9, 2022 | After the close | -0.38 | -0.37 | +2.6% |
| Aug 9, 2022 | Before the open | -0.30 | -0.35 | -16.7% |
| May 16, 2022 | Before the open | -0.31 | -0.28 | +9.7% |
| Mar 22, 2022 | Before the open | -0.34 | -0.27 | +20.6% |
| Nov 9, 2021 | Before the open | -0.31 | -0.24 | +22.6% |
| Aug 11, 2021 | Before the open | -0.30 | -0.26 | +13.3% |
| May 12, 2021 | Before the open | -0.30 | -0.26 | +13.3% |
| Mar 23, 2021 | Before the open | -0.36 | -0.28 | +22.2% |
| Nov 16, 2020 | Before the open | -0.38 | -0.33 | +13.2% |
| Aug 13, 2020 | Before the open | -0.42 | -0.36 | +14.3% |
| May 12, 2020 | Before the open | -0.54 | -0.35 | +35.2% |
| Mar 24, 2020 | Before the open | -0.52 | -0.58 | -11.5% |
| Nov 12, 2019 | Before the open | -0.45 | -0.33 | +26.7% |
| Aug 7, 2019 | Before the open | -0.49 | -0.39 | +20.4% |
| May 8, 2019 | Before the open | -0.52 | -0.47 | +9.6% |
| Mar 21, 2019 | Before the open | -0.44 | -0.27 | +38.6% |
| Nov 13, 2018 | Before the open | -0.53 | -0.31 | +41.5% |
| Aug 14, 2018 | Before the open | -0.57 | -0.53 | +7.0% |
| May 7, 2018 | After the close | -0.51 | -0.47 | +7.8% |
| Mar 20, 2018 | After the close | -0.53 | -0.80 | -50.9% |